IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
Biology · 30.10.2024 · 13 (11) · 885
DOI: 10.3390/biology13110885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 30.10.2024. Verfasst von Kristian A Choate und 4 weiteren Autor:innen. Beteiligte Einrichtung: Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 293 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In 2021, the World Health Organization classified isocitrate dehydrogenase (IDH) mutant gliomas as a distinct subgroup of tumors with genetic changes sufficient to enable a complete diagnosis. Patients with an IDH mutant glioma have improved survival which has been further enhanced by the advent of targeted therapies. IDH enzymes contribute to cellular metabolism, and mutations to specific catalytic residues result in the neomorphic production of D-2-hydroxyglutarate (D-2-HG). The accumulation of D-2-HG results in epigenetic alterations, oncogenesis and impacts the tumor microenvironment via immunological modulations. Here, we summarize the molecular, cellular, and clinical implications of IDH mutations in gliomas as well as current diagnostic techniques.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA.
- Department of Chemistry, Northern Michigan University, Marquette, MI 49855, USA.
- School of Clinical Sciences, Northern Michigan University, Marquette, MI 49855, USA.
- Department of Biology, Northern Michigan University, Marquette, MI 49855, USA.
Zitieren
APA
Choate, K. A., Pratt, E. P. S., Jennings, M. J., Winn, R. J., & Mann, P. B. (2024). IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications. Biology, 13(11), 885. https://doi.org/10.3390/biology13110885
Vancouver
Choate KA, Pratt EPS, Jennings MJ, Winn RJ, Mann PB. IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications. Biology. 2024;13(11):885. doi:10.3390/biology13110885
BibTeX
@article{Choate2024,
author = {Choate, Kristian A and Pratt, Evan P S and Jennings, Matthew J and Winn, Robert J and Mann, Paul B},
title = {IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications},
journal = {Biology},
year = {2024},
volume = {13},
number = {11},
pages = {885},
doi = {10.3390/biology13110885}
}
EUVIMED